Two posters presented at the CHEST 2024 annual meeting showed that mepolizumab significantly reduces exacerbations in ...

The U.S. Food and Drug Administration has approved Regeneron's Dupixent (dupilumab) as an add-on maintenance treatment for ...

As Hurricane Milton approaches the Gulf Coast, the American Lung Association has released critical health guidance for ...

Dupilumab improves health-related quality of life (HRQoL) in patients with chronic obstructive pulmonary disease (COPD) and ...

Hope is on the horizon for patients living with chronic obstructive pulmonary disease (COPD). CHEST 2024 in Boston featured a session highlighting emerging bronchoscopic therapies.

COIMBATORE: A total of 1,039 people have been diagnosed with early Chronic Kidney Diseases (CKD) in Coimbatore district ...

Inhalers used to treat symptoms of respiratory disease can be potent sources of greenhouse gases. Drugmakers are planning to ...

Dupilumab improves health-related quality of life (HRQoL) in patients with chronic obstructive pulmonary disease (COPD) ...

Respiratory viruses can remain hidden in immune cells in the lungs long after the initial symptoms of an infection have ...

Rural women with COPD face rising mortality rates, while urban women and men see declines. A new study highlights the social ...

Study reveals that COVID-19 significantly increases the risk of chronic fatigue syndrome, with specific populations, such as ...